{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:16:12Z","timestamp":1788844572368,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004488","name":"Croatian Science Foundation","doi-asserted-by":"publisher","award":["04.01\/56"],"award-info":[{"award-number":["04.01\/56"]}],"id":[{"id":"10.13039\/501100004488","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PLIVA Croatia LTD"},{"DOI":"10.13039\/100008993","name":"University of Zagreb","doi-asserted-by":"publisher","award":["Z1129"],"award-info":[{"award-number":["Z1129"]}],"id":[{"id":"10.13039\/100008993","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ejps.2017.03.018","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T09:16:05Z","timestamp":1489482965000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["HCE-T cell-based permeability model: A well-maintained or a highly variable barrier phenotype?"],"prefix":"10.1016","volume":"104","author":[{"given":"Marina","family":"Jureti\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisera","family":"Juri\u0161i\u0107 Dukovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Krtali\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Reichl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biserka","family":"Cetina-\u010ci\u017emek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Filipovi\u0107-Gr\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Lovri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Pepi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2017.03.018_bb0005","first-page":"614","article-title":"An Sv40-immortalized human corneal epithelial-cell line and its characterization","volume":"36","author":"Araki-Sasaki","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2017.03.018_bb0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0014-4835(03)00033-2","article-title":"Comparison of ultrastructure, tight junction-related protein expression and barrier function of human corneal epithelial cells cultivated on amniotic membrane with and without air-lifting","volume":"76","author":"Ban","year":"2003","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejps.2017.03.018_bb0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1089\/jop.2006.0095","article-title":"Expression of ABC-transporters in human corneal tissue and the transformed cell line, HCE-T","volume":"23","author":"Becker","year":"2007","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2017.03.018_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/026119290803600106","article-title":"A comparative evaluation of corneal epithelial cell cultures for assessing ocular permeability","volume":"36","author":"Becker","year":"2008","journal-title":"Altern. Lab. Anim"},{"key":"10.1016\/j.ejps.2017.03.018_bb0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ardp.19843170314","article-title":"Ph-solubility relationship and partition-coefficients for some anti-inflammatory arylaliphatic acids","volume":"317","author":"Chiarini","year":"1984","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejps.2017.03.018_bb0030","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/jps.21525","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: diclofenac sodium and diclofenac potassium","volume":"98","author":"Chuasuwan","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.03.018_bb0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejps.2015.04.003","article-title":"Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model","volume":"75","author":"Hafner","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.03.018_bb0040","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijpharm.2011.07.004","article-title":"Development of a serum-free human cornea construct for in vitro drug absorption studies: the influence of varying cultivation parameters on barrier characteristics","volume":"416","author":"Hahne","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.03.018_bb0045","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1002\/jps.23190","article-title":"Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies","volume":"101","author":"Hahne","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.03.018_bb0050","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejps.2017.03.018_bb0055","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s11095-010-0132-8","article-title":"Prediction of the corneal permeability of drug-like compounds","volume":"27","author":"Kidron","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2017.03.018_bb0060","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1124\/dmd.110.037622","article-title":"Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1-and OATP1B3-mediated drug transport","volume":"39","author":"Kindla","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.03.018_bb0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/jop.2011.0124","article-title":"mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs","volume":"28","author":"K\u00f6lln","year":"2012","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2017.03.018_bb0070","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.xphs.2016.04.010","article-title":"Cytochrome P450 activity in ex vivo cornea models and a human cornea construct","volume":"105","author":"K\u00f6lln","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.03.018_bb0075","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijpharm.2016.04.053","article-title":"Expression of glutathione transferases in corneal cell lines, corneal tissues and a human cornea construct","volume":"506","author":"K\u00f6lln","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.03.018_bb0080","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/mt.2012.144","article-title":"Terminal differentiation of cardiac and skeletal myocytes induces permissivity to AAV transduction by relieving inhibition imposed by DNA damage response proteins","volume":"20","author":"Lovric","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejps.2017.03.018_bb0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/ard.59.2.146","article-title":"Effects of cyclosporin at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells","volume":"59","author":"Maillefert","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejps.2017.03.018_bb0090","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.addr.2006.07.024","article-title":"Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics","volume":"58","author":"Mannermaa","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2017.03.018_bb0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/ICL.0b013e31804fa141","article-title":"Use of a human corneal epithelial cell line for screening the safety of contact lens care solutions in vitro","volume":"34","author":"McCanna","year":"2008","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ejps.2017.03.018_bb0100","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1248\/bpb.31.1444","article-title":"Contribution of aldehyde dehydrogenase 3A1 to disulfiram penetration through monolayers consisting of cultured human corneal epithelial cells","volume":"31","author":"Nagai","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejps.2017.03.018_bb0105","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1167\/iovs.08-2992","article-title":"Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage","volume":"50","author":"Pauly","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2017.03.018_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drudis.2013.08.002","article-title":"Toward the practical implementation of eye-related bioavailability prediction models","volume":"19","author":"Pepic","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2017.03.018_bb0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jps.24231","article-title":"Development of a convenient ex vivo model for the study of the transcorneal permeation of drugs: histological and permeability evaluation","volume":"104","author":"Pescina","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.03.018_bb0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/mp500401t","article-title":"Cellular uptake of Coumarin-6 under microfluidic conditions into HCE-T cells from nanoscale formulations","volume":"12","author":"Pretor","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2017.03.018_bb0125","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1211\/jpp.60.3.0004","article-title":"Cell culture models of the human cornea - a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro","volume":"60","author":"Reichl","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2017.03.018_bb0130","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/bjo.2003.028225","article-title":"Human corneal equivalent as cell culture model for in vitro drug permeation studies","volume":"88","author":"Reichl","year":"2004","journal-title":"Brit J Ophthalmol"},{"key":"10.1016\/j.ejps.2017.03.018_bb0135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/17425255.2011.562195","article-title":"In vitro cell culture models to study the corneal drug absorption","volume":"7","author":"Reichl","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejps.2017.03.018_bb0140","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1242\/jcs.113399","article-title":"Epithelial barrier assembly requires coordinated activity of multiple domains of the tight junction protein ZO-1","volume":"126","author":"Rodgers","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejps.2017.03.018_bb0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1517\/17460441.2014.892070","article-title":"Recent progress in tight junction modulation for improving bioavailability","volume":"9","author":"Saaber","year":"2014","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.ejps.2017.03.018_bb0150","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/js960529n","article-title":"Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy","volume":"86","author":"Sakai","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.03.018_bb0155","doi-asserted-by":"crossref","first-page":"L7","DOI":"10.1016\/0584-8539(95)01421-P","article-title":"Absorption and fluorescence properties of fluorescein","volume":"51","author":"Sjoback","year":"1995","journal-title":"Spectrochim. Acta A"},{"key":"10.1016\/j.ejps.2017.03.018_bb0160","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.tiv.2011.05.021","article-title":"Development of a human corneal epithelium model utilizing a collagen vitrigel membrane and the changes of its barrier function induced by exposing eye irritant chemicals","volume":"25","author":"Takezawa","year":"2011","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.ejps.2017.03.018_bb0165","first-page":"2942","article-title":"Culture model of human corneal epithelium for prediction of ocular drug absorption","volume":"42","author":"Toropainen","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2017.03.018_bb0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0928-0987(03)00173-8","article-title":"Paracellular and passive transcellular permeability in immortalized human corneal epithelial cell culture model","volume":"20","author":"Toropainen","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.03.018_bb0175","first-page":"280","article-title":"Migration of polarized epithelial cells through permeable membrane substrates of defined pore size","volume":"58","author":"Tucker","year":"1992","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ejps.2017.03.018_bb0180","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/jps.21878","article-title":"Effluxing ABC transporters in human corneal epithelium","volume":"99","author":"Vellonen","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.03.018_bb0185","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ijpharm.2012.10.007","article-title":"Expression analysis of MDR1, BCRP and MRP3 transporter proteins in different in vitro and ex vivo cornea models for drug absorption studies","volume":"441","author":"Verstraelen","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.03.018_bb0190","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1021\/mp400625z","article-title":"Multidrug resistance-associated protein (MRP1, 2, 4 and 5) expression in human corneal cell culture models and animal corneal tissue","volume":"11","author":"Verstraelen","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2017.03.018_bb0195","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s002040050349","article-title":"Membrane action of chloramphenicol measured by protozoan motility inhibition","volume":"70","author":"Wu","year":"1996","journal-title":"Arch. Toxicol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717301513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717301513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T18:03:03Z","timestamp":1568916183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717301513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":39,"alternative-id":["S0928098717301513"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.03.018","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HCE-T cell-based permeability model: A well-maintained or a highly variable barrier phenotype?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}